Adaptive Biotechnologies Corp. is a company in the U.S. stock market and it is a holding in 48 U.S.-traded ETFs. ADPT has around 19.1M shares in the U.S. ETF market. The largest ETF holder of ADPT is the ARK Genomic Revolution ETF (ARKG), with approximately 9.09M shares. Investors may also find of interest that the ETF with the largest allocation to ADPT stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 4.09%. On average, U.S. ETFs allocate 0.18% of ADPT to their portfolios.
Additionally, ADPT is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ADPT as a holding is the Invesco NASDAQ Future Gen 200 ETF (QQQS), with a return of --.